Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Luc Grislain is active.

Publication


Featured researches published by Luc Grislain.


International Journal of Pharmaceutics | 1983

Pharmacokinetics and Distribution of a Biodegradable Drug-carrier

Luc Grislain; Patrick Couvreur; V. Lenaerts; Marie Roland; D. Deprezdecampeneere; Peter Speiser

Abstract This paper describes tissue distribution, blood clearance and excretion of biodegradable cyanoacrylic nanoparticles. After intravenous administration, nanoparticles were rapidly cleared from the blood stream and concentrated mainly in the reticuloendothelial system. When administrated subcutaneously, nanoparticles seemed to avoid the liver and the spleen whereas they concentrated in the gut wall. Whole body autoradiography performed on Lewis Lung carcinoma-bearing mice showed progressive accumulation of the carrier in tumoral tissue. Furthermore a high level of radioactivity was found in the metastatic lungs of cancerous animals, whereas no lung accumulation was observed in healthy mice. Data are given concerning the enzymatic contribution to the degradation of the nanoparticles in vivo.


Pharmaceutical Research | 2003

The stenlying effect of high hydrostatic pressure on thermally and hydrolytically labile nanosized carriers.

Irène Brigger; Laurence Armand-Lefevre; Pierre Chaminade; Madeleine Besnard; Yohan Rigaldie; Alain Largeteau; Antoine Andremont; Luc Grislain; G. Demazeau; Patrick Couvreur

AbstractPurpose. To investigate whether high hydrostatic pressure (HHP) treatment allows the sterilization of thermosensitive polymer nanoparticle suspensions without jeopardizing their physicochemical integrity. Methods. Application of HHP was explored on a wide variety of thermosensitive poly(cyanoacrylate) nanoparticles, varying by their type (nanospheres or nanocapsules), by their preparation method (nanoprecipitation or emulsion/solvent evaporation), as well as by their surface characteristics. Physicochemical characterization before and after pressurization included turbidimetry, size measurement, zeta potential, scanning electron microscopy and infrared analysis. A sterility test also conducted according to pharmacopoeial requirements on an importantly contaminated nanoparticle suspension. Results. Poly(cyanoacrylate) nanoparticles appeared to be extremely baroresistant. Continuous or oscillatory HHP treatment up to 500 MPa during 30 min induced generally neither physical, nor chemical damage. However, precautions should be taken when surface modifiers are adsorbed onto nanoparticles, as a layer destabilization may occur. Finally, this process allowed the successful inactivation of vegetative bacteria, yeast, and fungi. Conclusions. This work proposes HHP as a new method for polymer drug carriers sterilization, taking into account that further exploration in this area is needed to propose novel protocols for spores inactivation.


Pharmaceutical Research | 2003

Effects of High Hydrostatic Pressure on Several Sensitive Therapeutic Molecules and a Soft Nanodispersed Drug Delivery System

Yohan Rigaldie; Alain Largeteau; Gilles Lemagnen; Fabienne Ibalot; Patrick Pardon; G. Demazeau; Luc Grislain

AbstractPurpose. According to the development in the last decade of industrial processes using high hydrostatic pressure (HHP) for preservation of several commercial food products, novel sterilization or decontamination processes for pharmaceutical products could be conceivable. The aim of this work is to evaluate the effects of HHP on the integrity of insulin and heparin solutions, suspension of monoclonal antibodies and Spherulites®. Methods. High performance liquid chromatography, thin layer chromatography, capillary electrophoresis assays, ELISA tests, laser granulometry and spectrophotometry analyses have been performed to compare HHP treated drugs (in a domain of pressure and temperature ranging respectively from 20 up to 500 MPa and from 20°C up to 37°C) vs. untreated ones. Results. No difference has been detected except for monoclonal antibodies that are altered above 500 MPa. Conclusions. The structure integrity of sensitive molecule due to the small energy involved by HHP and the development of industrial plants (intended for the decontamination of food products) confer to this technology the potential of a new method for sterilization of fragile drugs and an original alternative to aseptic processes and sterilizing filtration.


Journal of Pharmaceutical Sciences | 1982

Toxicity of Polyalkylcyanoacrylate Nanoparticles II: Doxorubicin-Loaded Nanoparticles

P. Couvreur; B. Kante; Luc Grislain; Marie Roland; Peter Speiser


Journal of Pharmaceutical Sciences | 1984

In Vivo Uptake of Polyisobutyl Cyanoacrylate Nanoparticles by Rat Liver Kupffer, Endothelial, andParenchymal Cells

V. Lenaerts; J.F. Nagelkerke; T. J. C. van Berkel; Patrick Couvreur; Luc Grislain; Marie Roland; P. Speiser


Archive | 2001

High pressure sterilising of sensitive active principles

Luc Grislain; Bruno Vallayer; G. Demazeau; Alain Largeteau; Gilles Lemagnen; Yohan Rigaldie


Defect and Diffusion Forum | 2002

Pharmaceuticals Perspectives of High Pressure: A Soft Tool for Sterilization of Fragile Drugs

Yohan Rigaldie; Gilles Lemagnen; Alain Largeteau; D. Larrouture; M. Abba; R. Haller; Luc Grislain; G. Demazeau


Archive | 2003

Method for inactivating micro-organisms by applying high pressures

Luc Grislain; G. Demazeau; Alain Largeteau; Yohan Rigaldie; Catherine Lacaze-Saint-Jean


Archive | 2006

Procédé de fabrication d'une forme pharmaceutique à libération contrôlée contenant au moins un principe actif

Catherine Lacaze Saint-Jean; Luc Grislain; Thomas Bergua; François Boutignon; G. Demazeau; Alain Largeteau


Archive | 2002

microorganism inactivation proceeds by applying high pressure

Luc Grislain; G. Demazeau; Alain Largeteau; Yohan Rigaldie; Saint Jean Catherine Lacaze

Collaboration


Dive into the Luc Grislain's collaboration.

Top Co-Authors

Avatar

G. Demazeau

University of Bordeaux

View shared research outputs
Top Co-Authors

Avatar

Yohan Rigaldie

École nationale supérieure de chimie et de physique de Bordeaux

View shared research outputs
Top Co-Authors

Avatar

Alain Largeteau

École nationale supérieure de chimie et de physique de Bordeaux

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marie Roland

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar

V. Lenaerts

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alain Largeteau

École nationale supérieure de chimie et de physique de Bordeaux

View shared research outputs
Top Co-Authors

Avatar

B. Kante

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar

D. Deprezdecampeneere

Université catholique de Louvain

View shared research outputs
Researchain Logo
Decentralizing Knowledge